Brigham and Women's Hospital — Boston, Massachusetts

Public research footprint of Brigham and Women's Hospital, compiled from the ClinicalTrials.gov public registry.

2,323

Registered studies

679

Active

347

Recruiting now

1,256

Completed

273

Stopped or withdrawn

Most-studied conditions

Metastatic Malignant Solid Neoplasm · Stage IV Lung Non-Small Cell Cancer AJCC v7 · Metastatic Lung Non-Small Cell Carcinoma · Unresectable Malignant Solid Neoplasm

Recently updated registry entries

NCT07536308 — A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike… (Recruiting)
NCT00114101 — Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell… (Active Not Recruiting)
NCT03842228 — Testing the Combination of the Anti-cancer Drugs Copanlisib, Olaparib, and MEDI4736… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Brigham and Women's Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.